FDA Device Intelligence
Home › Primonics (2006) Inc › TELEVISIT SOLUTIONS

TELEVISIT SOLUTIONS

Primonics (2006) Inc · Model TVS · UDI-DI 00628250477016

DQA Prescription
1
510(k) clearances
14,003
Adverse events (360 deaths)
128
Recalls
399
Facilities

Description

The Televisit software is intended for the purposes of collecting physiological data such as: Non-Invasive Blood Pressure; Pulse Oximetry, Temperature and Breath Sounds (Auscultation), Spirometer, Glucometer and E.C.G. The intended use of the Televisit software is in hospital/clinical environments with established specialized care providing access to each patient in their home and/or local community health center. Televisit software is a non-invasive medical device, which does not flag any abnormal results from the medical device inputs. The Televisit software does not monitor, assess or diagnose a disease, a disorder, or an abnormal physical state. The intended use for the software is data acquisition and collection only, with no treatment function or danger to the end user. The data obtained from Televisit software can be used only as an aid in the diagnosis and treatment of the patient.

Recalls

DateFirmReason
2025-10-24Edan DiagnosticsAs a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
2025-10-24Edan DiagnosticsAs a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
2025-10-24Edan DiagnosticsAs a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
2025-10-24Edan DiagnosticsAs a result of receiving an FDA It Has Come to Our Attention Letter (IHCTOA Letter) regarding potential cybersecurity issues with various of the firm device.
2025-06-23CovidienBedside SpO2 Patient Monitoring System alarms not heard/recognized, resulting in: treatment delay, lack of low oxygen saturation response, respiratory failure, arrhythmia. Highligh
2024-09-27Accriva Diagnostics, Inc.Values used to calibrate whole blood oximeter instruments were observed to be higher than normal, which may result in incorrect patient results where oxygen levels are higher than
2024-09-18Nihon Kohden America IncDue to oximeters not having FDA market approval or clearance to distribute in the U.S.
2024-09-18Nihon Kohden America IncDue to oximeters not having FDA market approval or clearance to distribute in the U.S.
2024-08-13Zoe Medical IncorporatedThis product labeling does not adequately provide warning about the risks associated with the use of damaged batteries or batteries past the intended use life.
2024-08-13Zoe Medical IncorporatedThis product labeling does not adequately provide warning about the risks associated with the use of damaged batteries or batteries past the intended use life.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API keyRead the docs
Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.